Another study predicted that M2-type TAMs enhance the CXCL1 and COL6A1 expression to advance the NSCLC metastasis via an NF-κB/PP2Ac positive feedback loop signaling pathway [518]. This evidence concerns the gene NFKB1 and non-small cell lung carcinoma.